ii4sm joins Tata Consultancy Services’ Co-Innovation Network (COIN™)
The International Institute for the Safety of Medicines Ltd (ii4sm) is pleased to announce that it has joined forces with Tata Consultancy Services (TCS) by entering the TCS Co-Innovation Network (COIN™). TCS an IT services, business solutions and outsourcing organization that delivers real results to global businesses, ensuring a level of certainty no other firm can match, has selected ii4sm as its partner under its TCS COIN™ initiative.
“COIN™ is an ecosystem for emerging technologies and high-tech business collaboration; it perfectly suits the innovative character of ii4sm’s activities, such as our computable semantics interoperability platform (CSI) that we are launching this month in the healthcare and life sciences market”, says Dr. Roland Haag, CEO of ii4sm.
TCS’ Co-Innovation Network (COIN™) is a rich and diverse network that provides value to its customers within the entire technology landscape. It is a network that connects several players, small and big, in the technology landscape creates true synergies in the innovation space. Read more information on the COIN™ initiative.
TCS's Innovation Labs attract the best talent as they are equipped with best in class infrastructure, and well networked with external academia and industry experts, to provide an environment that is conducive to harbouring sophisticated research. They explore leading-edge technologies and networks in collaboration with best-of-breed institutions to understand innovative and disruptive ideas. Over the past years, these labs have worked with its COINTM partners to develop path-breaking ideas, many of which have been successfully transformed into solutions for internal and commercial use.
“We are very proud of the fact that TCS selected our company to join its COIN™ program, an offer that is only extended to a small number of candidate companies. Through this cooperation we look forward to enrich our product portfolio of cutting-edge solutions in the fields of clinical development, drug safety and other domains in life sciences and healthcare. TCS will enable us to further increase the medical and economic value realized by our CSI platform and its new-generation smart health applications”, concludes Dr. Haag.
A part of the Tata Group, India’s largest industrial conglomerate, TCS has over 186,500 of the world's best trained IT consultants in 42 countries. The Company generated consolidated revenues of over US $6.3 billion for fiscal year ended 31 March 2010 and is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit www.tcs.com